Gadoteridol for MR imaging of lymphatic vessels in lymphoedematous patients: Initial experience after intracutaneous injection

British Journal of Radiology

Volumn 80, Issue 955, 2007, Pages 569-573

  Lohrmann, Christian ^a   Foeldi, E ^b   Bartholomae, J P ^a   Langer, M ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

^b Foeldi Clinic for Lymphology   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

GADOTERIDOL; MEPIVACAINE;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTRAST ENHANCEMENT; DIAGNOSTIC VALUE; FEMALE; HUMAN; IMAGE ANALYSIS; INGUINAL LYMPH NODE; LOWER LEG; LYMPH VESSEL; LYMPHEDEMA; LYMPHOGRAPHY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING;

ADULT; CONTRAST MEDIA; FEASIBILITY STUDIES; FEMALE; FOOT; HETEROCYCLIC COMPOUNDS; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; IMAGING, THREE-DIMENSIONAL; INJECTIONS, INTRADERMAL; LEG; LYMPHATIC VESSELS; LYMPHEDEMA; MAGNETIC RESONANCE IMAGING, INTERVENTIONAL; MALE; MIDDLE AGED; ORGANOMETALLIC COMPOUNDS;

EID: 34548319073     PISSN: 00071285     EISSN: None     Source Type: Journal    
DOI: 10.1259/bjr/95414884     Document Type: Article

References (16)

1. Runge VM, Bradley WG, Brant-Zawadzki MN, Carvlin MJ, DeSimone DN, Dean BL, et al. Clinical safety and efficacy of gadoteridol: a study in 411 patients with suspected intracranial and spinal disease. Radiology 1991;181:701-9.
2. Ball WS, Jr, Nadel SN, Zimmerman RA, Byrd SE, Dietrich RB, Prenger EC, et al. Phase III multicenter clinical investigation to determine the safety and efficacy of gadoteridol in children suspected of having neurologic disease. Radiology 1993;186:769-74.
3. Olukotun AY, Parker JR, Meeks MJ, Lucas MA, Fowler DR, Lucas TR. Safety of gadoteridol injection: US clinical trial experience. J Magn Reson Imaging 1995;5:17-25.
4. Cohan RH, Leder RA, Herzberg AJ, Hedlund LW, Wheeler CT, Beam CA, et al. Extravascular toxicity of two magnetic resonance contrast agents. Preliminary experience in the rat. Invest Radiol 1991;26:224-6.
5. Weissleder H, Weissleder R. Lymphedema: evaluation of qualitative and quantitative lymphoscintigraphy in 238 patients. Radiology 1988;167:729-35.
6. Suga K, Uchisako H, Nakanishi T, Utsumi H, Yamada N, Oohara M, et al. Lymphoscintigraphic assessment of leg oedema following arterial reconstruction using a load produced by standing. Nucl Med Commun 1991;12:907-17.
7. Ohtake E, Matsui K. Lymphoscintigraphy in patients with lymphedema. A new approach using intradermal injections of technetium-99m human serum albumin. Clin Nucl Med 1986;11:474-8.
8. Lohrmann C, Foeldi E, Langer M. Indirect magnetic resonance lymphangiography in patients with lymphedema. Preliminary results in humans. Eur J Radiol 2006;59:401-6.
9. Lohrmann C, Foeldi E, Speck O, Langer M. High-resolution magnetic resonance lymphangiography in patients with primary and secondary lymphedema. AJR Am J Roentgenol 2006;187:556-61.
10. Staatz G, Nolte-Ernsting CC, Adam GB, Grosskortenhaus S, Misselwitz B, Bucker A, et al. Interstitial T1-weighted MR lymphography: lipophilic perfluorinated gadolinium chelates in pigs. Radiology 2001;220:129-34.
11. Misselwitz B, Platzek J, Weinmann M. Early MR lymphography with gadofluorine M in rabbits. Radiology 2004;231:682-8.
12. Ruehm SG, Schroeder T, Debatin JF. Interstitial MR lymphography with gadoterate meglumine: initial experience in humans. Radiology 2001;220:816-21.
13. Ruehm SG, Corot C, Debatin JF. Interstitial MR lymphography with a conventional extracellular gadolinium-based agent: assessment in rabbits. Radiology 2001;218:664-9.
14. Foeldi M, Foeldi E, Kubik S. Textbook of lymphology, 1st edition. Munich, Germany: Elsevier, 2003.
15. Foeldi E. The treatment of lymphedema. Cancer 1998;83: 2833-4.
16. Schmid-Schonbein GW. Microlymphatics and lymph flow. Physiol Rev 1990;70:987-1028.